Increase in Funding
NIH funding to the Sanders-Brown Center on Aging increased from $13.3 million to $23.4 million in one year, a remarkable 75% increase in funding.
Beginning with only three faculty members, the Center has grown to more than 125 employees and to be one of the nation's leading centers on aging.
Card image

Drug studied at UK is first disease-modifying therapy in U.S. approved to treat Alzheimer’s

On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.


The UK-Alzheimer’s Disease Research Center (ADRC) is pleased to announce the Request for Applications for the UK-ADRC Developmental Project program.  This pilot project program, supported by the UK-ADRC, is aimed primarily at junior investigators (postdocs, assistant professors, senior research associates/scientists, clinical fellows), although we will also consider senior faculty who wish to move their research into dementia.

We will fund one developmental project of a two-year project duration, supported at $50,000 per year.  Applications are due March 1, 2024 with funding to start July 1, 2024.

Application details can be found here.

Please contact Linda Van Eldik (linda.vaneldik@uky.edu) or Daniel C. Lee (dan.lee@uky.edu) with any questions.



The Research Education Component (REC) of our UK-Alzheimer’s Disease Research Center has two REC Scholar positions open. Appointments are for one year, with the possibility of renewal for a second year.  This program is aimed at junior investigators (assistant professors or clinical fellows) to provide protected time/support to pursue mentored basic, translational, or clinical research relevant to Alzheimer’s disease and related dementias. Areas of special interest include studies on risk factors, prevention, preclinical AD, therapeutics, caregiving, minority populations, health disparities, cognitive processes, and neuroimaging.  The awards will provide seed funding to facilitate generation of pilot data for a future grant submission. Scholars will also follow a customized training plan to foster career development goals with mentored support.

Application details can be found here.  Applications are due on March 1, 2024 with funding to start on July 1, 2024.

Please contact Linda Van Eldik (linda.vaneldik@uky.edu) or Daniel Lee (dan.lee@uky.edu) with any questions.

Thirteenth Annual Markesbery Symposium on Aging & Dementia

The Thirteenth Annual Markesbery Symposium A Great Success

The thirteenth annual Markesbery Symposium on Aging and Dementia was held November 17 and 18th, 2023. The symposium, named in honor and memory of the late William R. Markesbery, MD, founding director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center, highlights the research being done at the Center as well as current research around the globe.  

This year Dr. Malu Tansey of the University of Florida and Dr. David Morgan of Michigan State University were the the keynote speakers at both Friday's Scientific Session and Saturday's Community Session.  They were joined by our very own Sanders-Brown Center on Aging experts.  To view their community presentations, click on the links below.

Why Gut Health Matters for Brain Health

Dr. Malu Tansey shares about gut health and its impact on the brain.

Immunotherapy for Alzheimer's Disease

Dr. David Morgan shares how immunotherapy is affecting Alzheimer's disease.

Card image

Mind Matters Magazine

Read the Mind Matters Magazine!